|
Volumn 46, Issue 3, 2002, Pages 848-853
|
Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPICILLIN;
DOXYCYCLINE;
OFLOXACIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BLOOD LEVEL;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
DISEASE COURSE;
DISEASE MODEL;
DOSE TIME EFFECT RELATION;
DRUG CLEARANCE;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MEGADOSE;
DRUG MONITORING;
HEART;
KIDNEY;
LEPTOSPIRA INTERROGANS;
LEPTOSPIROSIS;
LIVER LEVEL;
LUNG PARENCHYMA;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
QUANTITATIVE ASSAY;
SPLEEN;
SYRIAN HAMSTER;
AMPICILLIN;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
CRICETINAE;
DOXYCYCLINE;
LEPTOSPIRA;
LEPTOSPIROSIS;
MESOCRICETUS;
OFLOXACIN;
PENICILLINS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
|
EID: 0036174179
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.3.848-853.2002 Document Type: Article |
Times cited : (63)
|
References (26)
|